OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
Collin Vandemark, Jimmy Nguyen, Zhi‐Qing Zhao
Molecules (2023) Vol. 28, Iss. 3, pp. 1369-1369
Open Access | Times Cited: 15

Showing 15 citing articles:

Meta‐analysis on GLP‐1 mediated modulation of autophagy in islet β‐cells: Prospectus for improved wound healing in type 2 diabetes
Wenjing Xia, Hua Yu, Pengcheng Wen
International Wound Journal (2024) Vol. 21, Iss. 4
Open Access | Times Cited: 6

The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy
Chien-Yin Kuo, Sing‐Hua Tsou, Edy Kornelius, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access

GLP1R upregulation in mitral regurgitation observed at a single nucleus level
Sameeksha Tiwari, Martin Beyer, Sary F. Aranki, et al.
Journal of Molecular and Cellular Cardiology (2025)
Closed Access

Liraglutide Protects Cardiomyocytes against Isoprenaline-Induced Apoptosis in Experimental Takotsubo Syndrome
Zorislava Bajić, Tanja Šobot, Ljiljana Amidžić, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1207-1207
Open Access | Times Cited: 3

Pathophysiology of Angiotensin II-Mediated Hypertension, Cardiac Hypertrophy, and Failure: A Perspective from Macrophages
Kelly Carter, Eshan Shah, Jessica Waite, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 2001-2001
Open Access | Times Cited: 3

Activation of TLRs Triggers GLP-1 Secretion in Mice
L Lebrun, Aloïs Dusuel, Marion Xolin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5333-5333
Open Access | Times Cited: 6

Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology
Bhaskar Pal, Moitreyee Chattopadhyay
Journal of Diabetology (2024) Vol. 15, Iss. 1, pp. 24-37
Open Access | Times Cited: 1

Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease
Tianyu Wang, Juncan Ding, Xinyi Cheng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Exendin-4, a glucagon-like peptide-1 receptor agonist, regulates ductus arteriosus by vasodilation and anti-remodeling through the PKA pathway
Yi‐Ching Liu, Yu‐Hsin Tseng, Yen-Hsien Wu, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177106-177106
Closed Access | Times Cited: 1

GLP-1 Receptor Agonists: Beyond Diabetes—What the Neurosurgeon Needs to Know
Hael Abdulrazeq, Mazen Taman, Rohaid Ali, et al.
Neurosurgery Open (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 1

Pharmacological Research Progress of Novel Antihypertensive Drugs
Ling Huang, Ye Zhang, Xing Lü, et al.
Discovery Medicine (2024) Vol. 36, Iss. 184, pp. 882-882
Open Access

Research Progress on Peptide Drugs for Type 2 Diabetes and the Possibility of Oral Administration
Xinxin Yang, Ruiting Lin, C Feng, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1353-1353
Open Access

Page 1

Scroll to top